MYOM2 and plasma cell myeloma: It is a clinically asymptomatic premalignant clonal plasma cell or lymphoplasmacytic proliferative disorder defined by immunoglobulin (M protein) concentration less than 3 g/dl, plasma cells in the bone marrow less than 10%, and absence of myeloma-defining features or symptoms.